Search projects
17 projects found
GNA NOW
Novel Gram-negative antibiotic now
Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials
9
Impentri
Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)
Keywords: IMI projects Respiratory diseases Infectious diseases Coronaviruses Conducting clinical trials
10
ND4BB
New Drugs for Bad Bugs. Umbrella programme comprising the IMI projects TRANSLOCATION, ENABLE, COMBACTE-NET, COMBACTE-CARE, COMBACTE-MAGNET, COMBACTE-CDI, iABC and DRIVE-AB
Keywords: IMI projects Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Clinical networks Real-world data, evidence Drug discovery Economic model
11
PERISCOPE
PERtussIS COrrelates of Protection Europe
Keywords: IMI projects Infectious diseases Vaccines Conducting clinical trials
12
RespiriNTM
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials Target identification
13
RespiriTB
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials
14
TRIC-TB
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments
Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials
15
UNITE4TB
Academia and industry united innovation and treatment for tuberculosis
Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Clinical trial design Conducting clinical trials
16